Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citasoxacin vs levofloxacin in acute respiratory and urinary tract infections
CTR20170538Phase 3Suspended
- Sponsor
- Hainan Hualong Pharmaceutical
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citasoxacin in acute pharyngitis, acute tonsillitis, acute bronchitis, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), sponsored by Hainan Hualong Pharmaceutical. Started Jun 2017; status: suspended.
02
Drugs
citasoxacin
03
Conditions
acute pharyngitisacute tonsillitisacute bronchitischronic bronchitis (CB)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20170538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170538.